theophylline and alogliptin

theophylline has been researched along with alogliptin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asakura, M; Asano, Y; Asanuma, H; Ihara, M; Kato, H; Kitakaze, M; Minamino, T; Mochizuki, N; Mori, H; Shinozaki, Y; Sugimachi, M; Yamazaki, S	1

Other Studies

1 other study(ies) available for theophylline and alogliptin

Article	Year
An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. American journal of physiology. Heart and circulatory physiology, 2015, May-15, Volume: 308, Issue:10 Topics: Adenosine; Adenosine Deaminase; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dogs; Extracellular Signal-Regulated MAP Kinases; Female; Glucagon-Like Peptide 1; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Myocardial Reperfusion Injury; Piperidines; Protein Binding; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Antagonists; Theophylline; Uracil	2015

Article

Year

An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.

American journal of physiology. Heart and circulatory physiology, 2015, May-15, Volume: 308, Issue:10

Topics: Adenosine; Adenosine Deaminase; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dogs; Extracellular Signal-Regulated MAP Kinases; Female; Glucagon-Like Peptide 1; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Myocardial Reperfusion Injury; Piperidines; Protein Binding; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Antagonists; Theophylline; Uracil

2015